Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.
- Disease/Condition
- Leukemia
- Drug/Device/Intervention
- Who is Luke Eemia? Storybook
- Study type
- Interventional
- Intervention type
- behavioral
- Primary sponsor
- Children's Hospital Los Angeles
- Location
- Los Angeles, United States of America
- Phase
- N/A
- Start date
- Feb 03, 2024
- End date
- May 15, 2025
- Enrollment
- 140 participants
Parental Stress, prior to and following child life intervention
The goal of this clinical trial is to measure the effects of using a storybook versus
 standard child life intervention with parents of children newly diagnosed with leukemia on
 parental stress.
 
 The main questions it aims to answer are:
 
 - What effect will the storybook have on parent/legal guardian stress at three timepoints:
 baseline, discharge, and follow up?
 
 - Will this storybook impact parent/legal guardian comfort levels and improve their
 child's understanding?
 
 Participants will be asked to complete surveys at three timepoints, prior to and following
 child life intervention and about 3.5 months later. During child life interventions,
 participants will receive resources and support to explain leukemia to their school aged,
 3-16-year-old, child (patient or sibling).
 
 Researchers will compare Intervention and Control Groups to see if parental stress is lower
 in those who received the storybook in addition to the standard child life intervention
 versus the standard child life intervention alone.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06360718
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06360718 through Pure Global AI's free database. This phase not specified trial is sponsored by Children's Hospital Los Angeles and is currently Recruiting. The study focuses on Leukemia. Target enrollment is 140 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.